XNCR FY 2021 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$275M+124.2% YoY

Gross Profit

$275M100.0% margin

Operating Income

$44M15.9% margin

Net Income

$83M30.0% margin

EPS (Diluted)

$1.37

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$33M

Stock-Based Comp.

$37M

Balance Sheet

Total Assets

$838M

Total Liabilities

$105M

Stockholders' Equity

$734M

Cash & Equivalents

$143M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$275M	$123M	+124.2%
Gross Profit	$275M	-$47M	+684.0%
Operating Income	$44M	-$77M	+157.0%
Net Income	$83M	-$69M	+219.2%